|
Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >
Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer
Title: | Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer |
Authors: | Kano, Satoshi Browse this author →KAKEN DB | Homma, Akihiro Browse this author →KAKEN DB | Hatakeyama, Hiromitsu Browse this author →KAKEN DB | Mizumachi, Takatsugu Browse this author →KAKEN DB | Sakashita, Tomohiro Browse this author →KAKEN DB | Kakizaki, Tomohiko Browse this author | Fukuda, Satoshi Browse this author →KAKEN DB |
Keywords: | neutrophil-to-lymphocyte ratio (NLR) | platelet-to-lymphocyte ratio (PLR) | lymphocyte-to-monocyte ratio (LMR) | head and neck cancer | chemoradiotherapy |
Issue Date: | Feb-2017 |
Publisher: | Wiley |
Journal Title: | Head & neck |
Volume: | 39 |
Issue: | 2 |
Start Page: | 247 |
End Page: | 253 |
Publisher DOI: | 10.1002/hed.24576 |
PMID: | 27617428 |
Abstract: | Background: The purpose of this study was to analyze the relationship between pretreatment inflammatory markers and the prognosis of patients with oropharyngeal, hypopharyngeal, and laryngeal cancers. Methods: The data for 285 patients treated with curative intent by concurrent chemoradiotherapy (CRT) were obtained and their pretreatment inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) were calculated. Results: Significant relationships were observed between a high NLR and oropharyngeal or hypopharyngeal cancer, T3 to T4, N2b to N3, and clinical stage III to IV, whereas significant relationships were observed between a high LMR and laryngeal cancer, T1 to T2, and clinical stage I to II. With regard to survival outcomes, a high NLR, a high PLR, and a low LMR were all significantly associated with decreases in overall survival OS) and disease-free survival (DFS). Furthermore, multivariate analysis showed that LMR was an independent prognostic factor. Conclusion: Pretreatment LMR was found to be an independent prognostic factor for patients with head and neck cancers treated by concurrent CRT. |
Rights: | This is the peer reviewed version of the following article: Kano, S., Homma, A., Hatakeyama, H., Mizumachi, T., Sakashita, T., Kakizaki, T. and Fukuda, S. (2017), Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer. Head Neck, 39: 247–253, which has been published in final form at http://dx.doi.org/10.1002/hed.24576. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. |
Type: | article (author version) |
URI: | http://hdl.handle.net/2115/68256 |
Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 加納 里志
|